The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
ChemGenex reports successful personalized dosing of Quinamed at ASCO

MELBOURNE, Australia, and MENLO PARK, California U.S.A. (June 4, 2007). ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) announced today the presentation of data from its Quinamed (amonafide dihydrochloride) phase 1/2a dose-escalation study, designed to identify a genotypically optimised dose of Quinamed in heavily pre-treated patients with a variety of solid tumors. The key outcomes from this study were (i) demonstration that dose level could be optimised according to patient genotype, (ii) the drug was well tolerated, with predictable and manageable side effects, and (iii) there was evidence of anticancer activity in several solid tumor types.

Dr. John Kuhn of the University of Texas Health Science Center in San Antonio, TX, along with the investigators at Sarah Cannon Cancer Center, TN and University of Louisville, KY discussed the data in an oral presentation at the American Association of Clinical Oncology (ASCO) 43rd Annual Meeting in Chicago, Illinois.

The clinical activity of amonafide against a variety of cancers has long been recognized, but development has been hampered by the unpredictable side effect profile for patients said Dr Kuhn. We are excited by the new opportunities that personalized dosing of Quinamed offers for a range of solid tumor patients who have developed resistance to existing therapies.

Highlights of the presentation included:

  • Confirmation that genotyping of patients prior to treatment allows for optimized personalized dosing and improved drug tolerance.
  • Patients with rapid and intermediate acetylator genotypes (who more rapidly metabolize the drug to the acetylated derivative associated with side effects) achieved a maximum tolerated dose (MTD) of 320 mg/m2 of Quinamed weekly, whilst patients with slow acetylator genotypes achieved an MTD of 400 mg/m2 of Quinamed weekly (three weeks on treatment followed by one week off treatment, repeated). Using these dosing regimens, 64% of
    '"/>


Contact: Joan Kureczka
jkureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
4-Jun-2007


Page: 1 2

Related biology news :

1. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
2. 1 month post launch, Interactive Autism Network reports 13,000 participants
3. Biosite reports on presentation of preliminary data from sepsis program
4. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
5. Orexigen reports positive phase II results for Excalia Combination-Therapy to treat obesity
6. Dinosaurs climate shifted too, reports show
7. The New England Journal of Medicine reports data on eculizumab for the treatment of PNH
8. Portion distortion may contribute to expanding waistlines, study reports
9. Study reports findings on lung cancer death rates in never smokers
10. Breast implants not associated with cancer risk, study reports
11. Paper reports discovery of virus implicated in genetics of prostate cancer

Post Your Comments:
(Date:11/23/2009)...l Medical Sciences (NIGMS), part of the National I...ion for grants in scientific areas it identified a... grant program to stimulate biomedical research an... Recovery and Reinvestment Act (Recovery Act). , ... a significant impact on a field of biomedical sci...
(Date:11/23/2009)...rector of the Interuniversity Professorship in Law...e University of the Basque Country. The Professors...er experts such as researchers in the fields of mo...ethics. , The Interuniversity Professorship in L...usto and the Basque Country was created in 1993. T...
(Date:11/23/2009)...erman . , Of all global carbon dioxide emiss...where it contributes to global warming. The remain...stems such as forests, grasslands and peat-lands. ...restrial ecosystems is considered one of the main,...ange. However, new greenhouse gas bookkeeping has ...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2Intensive land management leaves Europe without carbon sinks 2Globus Medical Announces Launch of COALITION 28TM 29 ACDF Spacer System 47604 1Globus Medical Announces Launch of COALITION 28TM 29 ACDF Spacer System 47604 2EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 1EXTRA TV Features Tosca Renos Eat Clean Diets Libido Boosting Foods 47600 2Genomatica Produces Pure BDO From Natural Sugars 12413 1Genomatica Produces Pure BDO From Natural Sugars 12413 2Genomatica Produces Pure BDO From Natural Sugars 12413 3Genomatica Produces Pure BDO From Natural Sugars 12413 4
(Date:11/20/2009)..., , SEATTLE, Nov. 20 /PRNewswire-FirstCall...nnounced that the U.S. Food and Drug Administratio...Company,s amended Biologics License Application (B...e response. The FDA has assigned a Prescription D...hich time it will respond to Dendreon,s amended BL...
(Date:11/20/2009)..., , STOCKHOLM, November 20 /PRNewsw...that the European Investment Fund (EIF) has entere... The co-investment fund will be,managed by Karolin...s,portfolio of early-stage pharmaceutical and medi... 26.7 M Euros in the co-investment fund. The agree...
(Date:11/20/2009)... METTLER TOLEDO recently ...ctions Process Optimization Using At-Line Particle...ember 2, 2009. In this webinar, the application o...d to map the design space and optimize a series of...s, flow rates, and roller compaction forces. , ...
(Date:11/19/2009)... , Most people would like to be able to charge th...ckly and not too often. A recent discovery made by...ube-based supercapacitors that could do just this....ysics Letters , Prabhakar Bandaru, a professor in ...gineering, along with graduate student Mark Hoefer...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Nanotube defects equal better energy and storage systems 2
Other News:
..., May 2 While U.S. soldiers fighting in Iraq and ...s conflicts likely would have been fatal, the numb...ore been so high. Such injuries the partial or co...l injuries have profoundly affected the quality o...
...tlands are vital to the water cycle and havens for... an ESA-led initiative in collaboration with the R...this issue by using satellite imagery to provide d...aid national and local conservation efforts..........
...r in planning, the first Coyote Crisis Campaign (C...ing the week of April 24-28, 2006. The Biodesign I...ating emergency response coordination during a mas...xercise was the first major drill of its type betw...
...ed copying of a small segment of DNA in the genome...ransition of ancient animals from sea to land, or ...tes. The discovery is "tantalizing evidence" that ...an important source of evolutionary innovations, s...
DARPA grant supports research toward realizing tissue regeneration 2DARPA grant supports research toward realizing tissue regeneration 3DARPA grant supports research toward realizing tissue regeneration 4African wetland managers armed with new technology 2Biodesign Institute participates in first-of-its-kind 'coyote' disaster preparedness drill 2Biodesign Institute participates in first-of-its-kind 'coyote' disaster preparedness drill 3Biodesign Institute participates in first-of-its-kind 'coyote' disaster preparedness drill 4Mobile DNA part of evolution's toolbox 2Mobile DNA part of evolution's toolbox 3Mobile DNA part of evolution's toolbox 4
...y of California, San Francisco have. deciphered a ...ch T cell of the. immune system and may control th...al.. . When a virus, parasite or other pathogen in...ze the enemy, and a potent chemical signal is trig...
...es AIDS, may be adapted for use in gene therapy to...e system, even including AIDS, according to a scie...l Hill.. New findings released June 24 in the jour...hat a genetically stripped down amalgam of HIV com...
...e identified genes that may be involved in protect...step in the development of a drug or therapy for m...s a result of the disease.. . The research, prese...ng in Toronto, pinpoints three genes that may play...
...bank of information about the menstrual cycles of ...ars, known as The Tremin Trust, now resides at Pen...hers nationally and globally. . Originally called ... the project was started in the early 1930s by he...
Researchers decipher chemical 'cross talk' that determines survival of immunecells 2Researchers decipher chemical 'cross talk' that determines survival of immunecells 3Researchers decipher chemical 'cross talk' that determines survival of immunecells 4Modified HIV may be effective for delivering and regulating gene therapy 2Modified HIV may be effective for delivering and regulating gene therapy 3Genes may help protect kidneys from diabetes damage 265 years of women's menstrual cycles detailed 265 years of women's menstrual cycles detailed 3